Article Versions Notes

Rosato V, Nevola R, Dallio M, Di Micco P, Spinetti A, Zeneli L, Ciancio A, Milella M, Colombatto P, D’Adamo G, et al. Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration. Journal of Clinical Medicine. 2024; 13(19):5807. https://doi.org/10.3390/jcm13195807

Rosato, Valerio, Riccardo Nevola, Marcello Dallio, Pierpaolo Di Micco, Angiola Spinetti, Laert Zeneli, Alessia Ciancio, Michele Milella, Piero Colombatto, Giuseppe D’Adamo, and et al. 2024. "Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration" Journal of Clinical Medicine 13, no. 19: 5807. https://doi.org/10.3390/jcm13195807

Rosato, V., Nevola, R., Dallio, M., Di Micco, P., Spinetti, A., Zeneli, L., Ciancio, A., Milella, M., Colombatto, P., D’Adamo, G., Rosselli Del Turco, E., Gallo, P., Falcomatà, A., De Nicola, S., Pugliese, N., D’Ambrosio, R., Soria, A., Colella, E., Federico, A., ... Claar, E. (2024). Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration. Journal of Clinical Medicine, 13(19), 5807. https://doi.org/10.3390/jcm13195807